Pharma Marketing News Vol. 10, No. 5: 10 MARCH 2011

Welcome to Volume 10, Issue #5 (10 MARCH 2011) of Pharma Marketing News.

Double Dip in DTC Ad Spend!

Direct-to-Consumer (DTC) pharmaceutical advertising spending suffered a 'double dip' recession between 2007 and 2010, according to data presented in the AdAge Insights Whitepaper

The British Pharmaceutical Industry Issues Social Media Guidance for Adverse Event Reporting

Once again the Brits have beaten the US in issuing useful guidelines for social media use by the pharmaceutical industry! As I reported back in April, 2011, the Prescription Medicines Code of Practice Authority (PMCPA), which oversees the self-regulatory code of the Association of the British Pharmaceutical Industry (ABPI), published

Pharma Marketing News Vol. 10, No. 4: 23 FEBRUARY 2011

Welcome to Volume 10, Issue #4 (23 FEBRUARY 2011) of Pharma Marketing News.

Proposed Rules for Physician Payment Sunshine Act

Looming Challenges Cloud Implementation. This article reviews the strategic implications of the Sunshine Act and also presents highlights of the draft regulations rule released by the Centers for Medicare and Medicaid Services on December 15, 2011.

The Pharmaguy Social Media Timeline&trade: A Record of Social Media Events Impacting the Pharmaceutical...

The long-awaited social media guidance from the FDA -- whenever it arrives -- may turn out to be nothing more than a stamp of approval on activities in which the industry is currently engaged. Practically every issue that FDA guidance is expected to address has already been handled independently by a few pioneering pharmaceutical companies. Rather than waiting for FDA's anti climatic guidelines, Pharmaguy decided to publish The Pharmaguy Social Media Timeline™ now, at a time when the industry already has set precedents in every social media application.

Pharma Twitter Pioneers Recognized

More and more pharmaceutical company employees are using Twitter. Pharmaguy is looking at pharma employees who have personal Twitter accounts, how they use these accounts, who follows them and whom they follow, and how influential they are. This article is an introduction to the first round of members of this group.

Orphan Drugs Now “Where the Money Is,” Says Willie Sutton’s Ghost

Why do pharma companies bother developing drugs for for a disorder affecting fewer than 200,000 people? Willie Sutton's ghost may have the answer.

Pharma Marketing News Vol. 10, No. 11: 21 June 2011

Welcome to Volume 10, Issue #11 (21 JUNE 2011) of Pharma Marketing News.

Most Credible Bad Ad Complaints are Submitted by Pharma

According to a Bad Ad Program 2010-2011 Year End Report just issued by the FDA, the program is a success despite the fact that ONLY 125 complaints were deemed worthy of
- Advertisement -